- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
International Journal of Dentistry
Volume 2012 (2012), Article ID 821383, 14 pages
Host-Bacteria Crosstalk at the Dentogingival Junction
1Department of Periodontology, Institute of Dentistry, University of Turku, Lemminkäisenkatu 2, 20520 Turku, Finland
2Department of Cariology, Institute of Dentistry, University of Turku, Lemminkäisenkatu 2, 20520 Turku, Finland
3Department of Biochemistry and Food Chemistry, University of Turku, 20520 Turku, Finland
4Department of Periodontology, Institute of Dentistry, University of Helsinki, 00014 Helsinki, Finland
5Department of Oral and Maxillofacial Surgery, Helsinki University Central Hospital, 00290 Helsinki, Finland
Received 10 April 2012; Revised 22 May 2012; Accepted 22 May 2012
Academic Editor: Edvaldo Antonio Ribeiro Rosa
Copyright © 2012 M. T. Pöllänen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The dentogingival junction is of crucial importance in periodontal host defense both structurally and functionally. Oral bacteria exert a constant challenge to the host cells and tissues at the dentogingival junction. The host response is set up to eliminate the pathogens by the innate and adaptive defense mechanisms. In health, the commensal bacteria and the host defense mechanisms are in a dynamic steady state. During periodontal disease progression, the dental bacterial plaque, junctional epithelium (JE), inflammatory cells, connective tissue, and bone all go through a series of changes. The tissue homeostasis is turned into tissue destruction and progression of periodontitis. The classical study of Slots showed that in the bacterial plaque, the most remarkable change is the shift from gram-positive aerobic and facultatively anaerobic flora to a predominantly gram-negative and anaerobic flora. This has been later confirmed by several other studies. Furthermore, not only the shift of the bacterial flora to a more pathogenic one, but also bacterial growth as a biofilm on the tooth surface, allows the bacteria to communicate with each other and exert their virulence aimed at favoring their growth. This paper focuses on host-bacteria crosstalk at the dentogingival junction and the models studying it in vitro.
1. Microorganisms in Subgingival Biofilm
The presence of the initial colonizers on the tooth surface is essential for the emergence of the gram-negative periodontopathogens Porphyromonas gingivalis, Tannerella forsythia (Bacteroides forsythus), Aggregatibacter actinomycetemcomitans, and Fusobacterium, Prevotella, Campylobacter, and Treponema species [1–3]. Recently also gram-positive genera such as Peptostreptococcus and Filifactor have been suggested to play roles in periodontitis . The genera Megasphaera and Desulfobulbus have also been found to be elevated in periodontitis, even to a larger extent than species traditionally implicated as periodontopathogens . Recent studies have also identified Staphylococcus aureus in pockets of the majority (60,5%) of nonsmoking patients with aggressive periodontitis . In addition to known periodontal pathogens, other bacterial species, such as Pseudoramibacter, Bacteroidetes, Sphorocytophaga, Shuttleworthia, Dialister, Mogibacterium, Mycoplasma, Synergistes, and Acidaminococcaceae, seem to exist at high levels in patients with refractory nature of periodontitis .
Microorganisms other than bacteria have also been found in periodontitis patients. Candida species have been detected in 15–21% of periodontitis patients as well as in healthy subjects [3, 7–9]. The coexistence of, for example, Epstein-Barr and human cytomegalovirus together with periodontopathogens has also been implicated to play a role in periodontal pathogenesis .
Although novel detection methods have allowed the recognition of new species that could be involved in the pathogenesis of periodontitis, recent studies suggest that the whole composition, rather than single species, influence the pathogenicity of the biofilm [11, 12]. In addition to the protective structures of multispecies biofilm which inhibit the actions of host defense cells, the molecular interactions between different species [13, 14] in the oral biofilm could influence the virulence of the bacterial community. Especially quorum sensing signal, autoinducer-2, is used in inter-species signaling between various periodontal pathogens, and it may enhance the formation of the biofilm as well as change the virulence gene expression . Moreover, by weakening the host defense, opportunistic periodontal pathogens, such as P. gingivalis, may allow the overgrowth of commensal oral species which leads to detrimental inflammation and periodontal bone loss .
2. The Junctional Epithelium-Bacteria Interactions
The first line of innate host defense in the periodontal region is the JE that hinders bacterial advancement into periodontal tissues, Figure 1(a). JE is a unique epithelial structure firmly attached to the hard tissue of tooth via hemidesmosomes. The cells directly attached to the tooth, DAT-cells , have been shown to be dividing cells like the basal cells. Rapid renewal and constant shedding of the JE cells towards the sulcus together with the gingival crevicular fluid (GCF) flow are efficient inhibitors of bacterial colonization. This is further strengthened by the external basal lamina (EBL) and internal basal lamina (IBL) that function as barriers to bacterial advancement, yet allowing the passage of leukocytes and their antimicrobial agents and antibodies into the gingival crevice. Interestingly the composition of the IBL and EBL differs from each other and also seems to differ from the basement membrane of the outer gingival epithelium, suggesting a very different role for these basement membranes . Whereas the IBL is dedicated to maintain the attachment to the tooth, the EBL functions merely as a protective barrier. The JE cells actively facilitate leukocyte recruitment to the site of inflammation by expressing chemotactic factors (IL-8 and complement C5a) and factors such as ICAM-1 that aid leukocyte course from the blood vessels [19–22]. The active role of the JE in the innate host defense is further demonstrated by the production of cytokines and the presence of natural antimicrobial peptides and proteins such as the defensins, the cathelicidin family members (LL-37), and calprotectin [23–25]. Human beta-defensins (hBDs) are expressed in gingival epithelia, salivary glands, saliva, and GCF [26–28] as a response to bacterial challenge [29–31]. Calprotectin, expressed in neutrophils, monocytes, and gingival keratinocytes, protects gingival keratinocytes against binding and invasion by P. gingivalis . Alpha-defensins secreted by neutrophils are bound to junctional and pocket epithelium serving as an additional antimicrobial function . It has been shown that JE cells lateral to DAT cells produce matrilysin (MMP-7) . This enzyme is able to activate the precursor peptide of alpha-defensin, an important antimicrobial agent of mucosal epithelium . It is possible that a similar active matrilysin/defensin system exists in JE, as in other mucosa exposed to bacteria such as intestine and lungs .
A prerequisite for the bacteria to “win the battle” and gain more living space subgingivally appears to be degeneration of the DAT cells (Table 1). Alternatively, degradation of IBL on the tooth surface and consequently detachment of the JE takes place. A third possibility is bacterial invasion into JE cells and formation of an intraepithelial split that then results in periodontal pocket formation. These initial events in periodontal tissue destruction/pocket formation are surprisingly poorly known, Figure 1(b). Decreased mitosis and increased apoptosis of gingival epithelial cells has been shown at sites exhibiting severe inflammation . Bacterial internalization in a tissue culture model and in vivo in severe periodontitis followed by epithelial cell apoptosis have also been demonstrated [70, 71]. A simultaneous application of LPS and proteases to rat gingiva has been found to cause apoptosis of connective tissue and periodontal ligament fibroblasts followed by apical migration of the JE .
During bacterial challenge the host cells recognize the bacteria and different antigens by different receptors that have been detected also on periodontal tissues. Toll-like receptor-2 (TLR-2), that recognizes, for example, bacterial peptidoglycans (PGN), lipoproteins, and LTAs has been found in abundance in the membrane of pocket epithelial cells as compared to the gingival tissues of healthy controls . Protease activated receptors (PARs) mediate cellular responses to extracellular proteinases such as thrombin and trypsin-like serine proteases. PARs are expressed in human neutrophils, gingival fibroblasts, and osteoblasts [74, 75]. In vitro experiments have shown that P. gingivalis proteases stimulate PARs also in oral epithelial cells leading to proinflammatory cytokine IL-6 and IL-8 secretion [31, 76]. However, P. gingivalis may also have an opposite effect, since P. gingivalis invasion into epithelial cells has been shown to block IL-8 production and thus it may affect the chemotactic IL-8 gradient in the JE. [77, 78] In vitro studies have suggested that PAR-2 receptors expressed in gingival keratinocytes may contribute to hBD expression when challenged by gingipains, TNF-alpha or IL-1beta . However, it seems that a certain threshold exists to inflammatory and bacterial challenge and the expression of hBDs, since in chronic (advanced) periodontitis the expression of hBDs-2 and -3 is reduced . Application of PAR agonist peptide to gingiva has induced periodontitis in rats (radiographically assessed bone loss, myeloperoxidase (MPO) activity) . Thus the activation of PARs seems to be important for the protective host response at the periodontal region. Whether modulation/activation/suppression of these cellular receptors can be used in periodontal therapy remains to be studied.
3. Connective Tissue (Fibroblasts and MMPs) Response to Bacterial Challenge
Gingival CT is composed of extracellular matrix (ECM) and fibroblasts producing the ECM and participating immune and inflammatory responses of the gingiva. The ECM comprises of fibers (mainly collagen I), proteoglycans, glycoproteins and water. CT is constantly renewed and that requires degradation of the ECM components, therefore gingival fibroblasts also produce proteolytic enzymes, MMPs. The MMPs are controlled by tissue inhibitors of MMPs (TIMPs) and in healthy periodontal tissue the TIMP levels exceed MMP . Bacteria at the gingival margin causes drastic changes in CT; vascular permeability and the amount of inflammatory cell infiltrate are increased. Fibroblast functions are altered; cell proliferation and collagen production are impaired and components of extracellular matrix are degraded [81–84]. This is thought to result from both host- and bacteria-derived agents, such as lipopolysaccharides (LPSs), inflammatory cytokines, for example, IL-1beta, and TNF-alpha and to a lesser extent also by IL-17, growth factors and hormones [80, 85, 86] that activate leukocytes, fibroblasts, and epithelial cells leading to production of prostaglandins and MMPs and causing destruction of the CT [72, 87, 88]. In addition to the activation of the latent forms of MMPs, bacteria-derived proteinases may inactivate proteinase inhibitors such as alpha-1-antitrypsin and alpha-2-macroglobulin and thus result in higher levels of active proteinases [89–92]. Increased amounts of MMP-1, -2, -3, -8, -9, and -13 have been found in GCF and gingiva of periodontitis patients compared with samples from healthy controls [22, 85, 93–99]. Increased levels of MMPs and decreased amounts of their tissue inhibitors have been connected to the progression of periodontal disease [100, 101]. The destruction of CT in the periodontal region seems to be the result of synergistic action of both bacteria and host derived proteinases leading to an imbalance of the proteinases over their inhibitors . Furthermore, a recent study on experimental periodontitis showed dual changes in CT; simultaneous collagen fiber breakdown and fiber bundle thickening, and suggested a protective role for the inflammatory tissue breakdown in order to avoid the spreading of the infection into the deeper areas .
4. Crosstalk between the Bacteria and Polymorphonuclear-Leukocytes, Complement and Macrophages
PMNs are the main leukocytes isolated from gingival crevice. They are the first defense cells to respond to bacterial stimulus and they are present within minutes after stimulus. In the dentogingival area the bacteria are always present and the migration of PMNs and macrophages/monocytes into the gingival crevice is continuous. Thus even clinically healthy gingiva demonstrates some neutrophils in JE and the underlying CT . Neutrophils are viable and functional in the gingival crevice. The “leukocyte wall”  is formed by neutrophils between the plaque and the junctional and sulcular epithelium. The leukocyte wall has proteolytic, phagocytic, and antibacterial (MPO, defensins, and other antibacterials such as lactoferrin) features. Although aimed against the bacteria, PMN activation and especially premature release of their granule products such as proteolytic enzymes and reactive oxygen species play a central role in periodontal tissue destruction [105, 106]. PMNs are essential in the first line of innate defense against plaque bacteria at the gingival margin. When the PMNs come to contact with the bacteria, they release their granular contents, adhere to individual bacteria and attempt to phagocytose them. The PMNs are a major contributor in the host parasite equilibrium but when activated can also cause tissue damage due to excess of enzymes, reactive oxygen species, MMPs, and other components that are released from their granules during the battle against microbes [48, 107–111].
Proteases such as elastase, cathepsin G, and MMPs, of which MMP-8, and MMP-9 are mainly originated from neutrophils, are able to degrade a wide variety of host cellular and extracellular components . The fact, that when MMP activity is inhibited, tissue destruction is reduced, further emphasizes the role of MMPs on tissue destruction .
The main role of PMNs, however is phagocytosis and the PMNs in the gingival tissues are the main controllers of the microbial ecology within the gingival crevice. The cross-talk between neutrophils and immune cells is constant. Neutrophils have surface receptors for both complement (C5a-receptor) and immunoglobulin (Fc gamma-receptors) and the interaction with opsonized bacteria leads to phagocytosis of the bacteria. However, some periodontopathogens may escape PMN phagocytosis and even cause PMN death when ingested. Complement mediated phagocytosis of A. actinomycetemcomitans has been found inefficient regardless of the strain serotype, the majority of ingested A. actinomycetemcomitans staying viable. Furthermore, when opsonized with antibody, A. actinomycetemcomitans has caused rapid death of the PMNs . Impaired PMN functions are generally considered to be related to periodontal tissue destruction and patients with reduced number of neutrophils or impaired neutrophil function show often severe periodontitis . Smoking also impairs neutrophil functions, for example, phagocytosis . However, some studies have indicated that, in contrast to impaired function, PMN hyperreactivity may play a role in periodontitis . Increased oxygen radical and elastase release in response to bacterial stimulation has been connected, for example, to Fc gamma polymorphism (receptor RIIa131H/H genotype) . The innate nature of PMN hyperresponsiveness is supported by a study showing high levels of PMN oxygen radical production in periodontitis patients also after periodontal treatment .
If the PMN dependent defense is insufficient, the inflammation is prolonged and lymphocytes, macrophages, and plasma cells start to dominate the infiltrate. This leads to the release of the proinflammatory cytokines (e.g., IL-1, IL-6, IL-8, and TNF-alpha) and prostaglandins (e.g., PGE2), and the adaptive immune response is set up. A shift in the balance between anti-inflammatory and proinflammatory cytokines may be crucial for the progression of periodontitis. TGF-beta is an anti-inflammatory cytokine that also inhibits epithelial cell proliferation. In healthy JE integrin activates the latent TGF-beta. In inflamed pocket epithelium, however, integrin is absent allowing high epithelial proliferation .
The nonspecific innate immune system provides an immediate response, recognizing the difference between self-components and foreign molecules in the periodontal region. The microbial recognition is based on interaction between microbial ligands known as pathogen-associated molecular patterns (PAMPs) (e.g., LPS, LTA, peptidoglycan (PGN), and fimbriae) and pattern-recognition receptors (PRRs) of host. Host PRRs may be either soluble (e.g., complement), membrane-bound (like TLRs, on the cells involved in immune response), or cytosolic (like nucleotide-binding oligomerization domain proteins, Nods, e.g., in epithelial cells lining mucosal surfaces and in phagocytes), for a review see: . In most cases the interaction of PAMP with PRR leads to the production of proinflammatory cytokines and activation of inflammation reaction. However, various pathogenic bacteria including P. gingivalis may exploit the PRRs to undermine the bacterial killing, or use them to enable protected entry routs to host defense cells .
Complement system is the immediate and major humoral component of innate immune response . It is activated immediately in the presence of a pathogen. The action of the complement system affects both innate and adaptive immunity and thus has an important role in inflammatory and immune responses. The complement system is a biochemical cascade of the small plasma proteins that activate another in series. Many of the complement proteins are proteases. They are stored and secreted as inactive proenzymes. Normally they are distributed throughout the body without adverse effects. At site of infection proenzymes become proteases and produce local inflammatory responses. There are three separate pathways of complement activation. The pathways include the classical pathway, the alternative pathway and the lectin-mediated pathway. The alternative pathway is activated directly by bacteria-C3 interaction, and the classical pathway by the antigen-antibody interaction with C4 [122–125]. The C3 fragment is important in all three pathways. In the periodontal region T. denticola has been shown to activate C3 by chymotrypsin like protease dentilisin and P. gingivalis both C3 and C5 by cysteine protease gingipain-1. This leads to formation of C3a, C3b, and C5a [126, 127]. The C3b molecule opsonizes pathogens and thus targets them to phagocytosis. C3a and also C5a in turn act as chemoattractants for phagocytes and activate mast cells. Mast cells contribute to the inflammatory reaction by releasing histamine, inflammatory mediators and cytokines such as leukotrienes. Mast cells show MMP-1, -2, and -8 activity which is linked to periodontal tissue breakdown . Furthermore, complement activation increases vascular permeability and attracts phagocytes to the inflammatory site. In the periodontal region complement proteins and activation products have been detected in GCF and in the periodontal tissues both in health and disease [123, 129–131]. It has been suggested that complement deposits in connective tissue may reflect disease-associated complement activation . Several activated complement components form a membrane attack complex (MAC), which creates a transmembrane pore leading to the lysis of the target cell and may thus lead to destruction of both bacterial and host cells. MAC inhibitor, CD59, is expressed in gingival epithelium and thus gingival epithelium is probably well-protected against MAC mediated cell damage . Interestingly, the action of periodontal bacteria on complement seems to be biphasic. In addition to activation, periodontal pathogens such as P. gingivalis and A. actinomycetemcomitans may evade human complement mediated killing. Gingipains are proteases secreted by P. gingivalis. They degrade complement proteins. Other P. gingivalis proteinases inactivate leukocyte C5a receptor and A. actinomycetemcomitans serotype b lipopolysaccharide fails to interact with complement-derived opsonins [132–135]. In addition to the impaired pathogen-mediated complement activation, a clinical study has found partial gene deficiencies in complement C4 genes in patients suffering from chronic recurring periodontal inflammation . C4 deficiencies have been previously associated with chronic mucosal infections and the authors suggested that it may also predispose to periodontal infections. However, the role of complement in periodontal diseases still needs further studies.
Precursors of the monocyte/macrophage lineage may differentiate into macrophages, dendritic cells, or osteoclasts . Macrophages are efficient phagocytes and are abundant within the gingival tissues. They express TLRs that interact with PAMPs (LPS, LTA, and PGN) and release proinflammatory cytokines (IL-1, TNF-alpha, IL-6, and IL-12) and chemoattractants (e.g., IL-8). When differentiated into dendritic cells macrophages participate in antigen presentation by expressing costimulatory molecules and MHC-II molecules . Dendritic cells form the crucial link between the innate and adaptive immunity. Langerin is a transmembrane cell surface protein which plays a role in antigen recognition and uptake. Langerhans cells, identified by the C-type lectin langerin, are dendritic cells responsible for the presentation of antigens to T-lymphocytes. In healthy gingival epithelium also large numbers of resident Langerin+ Langerhans cells have been found . In periodontitis their number decreases intraepithelially and increases in connective tissue where antigen presentation takes place. The cells of the monocyte/macrophage lineage are important for the inflammatory reaction and also stand in the turning point of the adaptive host response. In addition, when differentiated to osteoclasts or via RANKL (receptor activator of nuclear factor kappa B-ligand) activation the monocyte-macrophage lineage cells also contribute to bone resorption . Hyperreactive monocyte/macrophage IL-1 genotype has been connected to increased periodontal tissue destruction [138–140]. However, the connection between the IL-1 gene polymorphism and the clinical manifestations of periodontal disease do not seem to be likewise certain in all populations [141, 142].
5. The Role of the Specific (Adaptive) Immune Defense in Host-Bacteria Crosstalk
The innate immune system is a crucial part of the defense at the early stages of infection and further controls the emergence of the adaptive immune response  (Table 2). Periodontal pathogens may also evade or escape the innate defense mechanisms and in such cases the cells of the adaptive immune response have an important role in recognizing the pathogens and initiating specific defense targeted to the pathogens involved. The key cells of the adaptive immune defense are the T-lymphocytes (T-helper-1 (Th1), T-helper-2 (Th2), and T-killer-cells) and B-lymphocytes . They have receptors (T-cell receptor, TCR, and B cell antigen receptor, BCR) on their surface that recognize and respond to bacterial antigens. Bacterial antigens coupled with antigen presenting cells with major histocompatibility complex (MHC) class-I molecules are recognized by T-killer cells and B cells. T-helper cells (Th1- and Th2-cells) recognize antigens coupled to class II MHC molecules. The recognition of the antigens in conjunction with costimulation with tumor necrosis factor (TNF) molecules leads to activation of the lymphocytes, production of the proinflammatory and/or anti-inflammatory cytokines (respectively Th1:IFN-gamma, IL-2, IL-12, and TNF-beta, Th2: IL-4, IL-5, IL-6 IL-10, and IL-13) and/or antibodies (by B cells; plasma cells/memory B cells). Both Immunoglobulin G and A (IgG and IgA) seem to be important to periodontal defense and are found in periodontal tissues and saliva [145–147]. During periodontal disease progression the levels of IgG and IgA against A. actinomycetemcomitans and P. gingivalis increase, and they correlate with the existing periodontitis and pathogen carriage in saliva [146, 147].
Although the immune response is primarily aimed to protect the host from the bacteria, it also seems to be strongly involved in tissue destruction in the periodontal region, Figure 1(c). Different models of tissue protection and destruction by the lymphocyte activation have been proposed [148–150] and the role of the different subsets of T-lymphocytes at different stages of the disease is still a matter of question. The anti-inflammatory cytokine profile of the Th2 response, low levels of costimulatory molecules and B-cell dependent antibody production have been suggested to dominate in cases of commensal bacteria, nonsusceptible patients and protective immune response whereas the periodontopathogenic bacteria are thought to trigger the proinflammatory Th1 cytokine response resulting in inflammatory periodontal bone resorption [88, 149–151]. Th1 cells express on their surface RANKL capable to bind to RANK on osteoclast precursor cells and thus directly induce osteoclastic bone resorption [152, 153]. Alternatively the cytokines produced by Th1 cells can indirectly lead to bone resorption by inducing RANKL expression on osteoblasts that can bind to RANK on osteoclast precursor cells and activate osteoclast differentiation . However, different models have also been proposed where the Th2 cell response has been connected to periodontal bone destruction by uncontrolled B-cell production of IL-1 or B-cell expression of RANKL [152, 154]. Also osteoprotegerin (OPG), the known decoy receptor for and inhibitor of RANKL may regulate and protect the host from inflammatory bone resorption, since interference with RANKL by systemic administration of OPG has resulted in abrogation of periodontal bone resorption in a rat model . Recent studies on humans have also suggested that in chronic periodontitis tissues a marked reduction in RANKL/OPG mRNA ratio may explain the immune response dependent bone resorption [155, 156].
6. In Vitro Models Studying Host-Microbe Interaction
Host-microbe interaction leading to periodontal pocket formation is a complex process, involving the presence of pathogenic bacterial biofilm as well as a susceptible host defense system. Improved methods to detect bacteria in periodontal biofilm have broadened our knowledge about pocket-associated microbes. In spite of the wide range of innate defense mechanisms at the dentogingival junction, the bacteria are able to surpass the host defense. Many of the periodontal pathogens take advantage of the host defense and thus enhance their growth in biofilm. It is clear that degradation of periodontal connective tissue and bone due to inflammation is an important part of the pocket formation. However, the most coronal part of the JE attached to the tooth appear to stand in first line of periodontal defense. Yet surprisingly small number of studies has been done on this early host-microbe interaction. The wide intercellular spaces and permeability of the JE, even though beneficial for the host defense, also allow bacteria and their harmful products to penetrate epithelium, which thereby activate the inflammatory reaction. The initial events of periodontal pocket formation are likely to involve destruction of the dento-epithelial junction resulting in the failure of the epithelial barrier function.
Monolayers of epithelial and connective tissue cells as well as planktonic bacteria have been widely used in studies on periodontal host-microbe interactions. Such experimental setups however lack important issues, for example, cell-cell contacts of the multilayered epithelium, the basement membranes and the epithelium-connective tissue interface as well as the microbial pathogenicity of the biofilm. As stated before in this paper, bacteria behave differently in biofilms, where some virulence genes are expressed due to the quorum sensing signaling. Different models of periodontal multilayer tissue cultures have been developed since the 1980s . Two kinds of models have been used in our laboratory, Figures 2(a) and 2(b). The primary tissue culture model of JE Figure 2(a), in which a piece of masticatory mucosa is placed on a permeable filter, allows studies, for example, bacterial components on the dentogingival junction in vitro. Application of A. actinomycetemcomitans LPS into the culture medium has resulted in migration of the in vitro JE into the CT, Figure 3. Although this model is a very delicate and excellent model, it is difficult to repeat and individual variation may influence the results. The other model, Figure 2(b), originally presented by Oksanen and Hormia , uses cell lines of either oral or skin origin and further includes a piece of tooth onto which the JE is formed Figure 4. This model is easier to repeat and allows also the placement of bacterial biofilms on top of the culture. With this model F. nucleatum biofilm was shown to induce epithelial antimicrobial peptides human beta defensins 2 and 3 .
The organotypic tissue culture models are convenient systems to study how periodontal pathogens penetrate not only to the cells but also to the cell layers. A. actinomycetemcomitans passes through the gingival cell layers quickly intercellularly, whereas P. gingivalis invades the cell layer more slowly by using also intracellular route . In addition, the biofilm mode of growth may alter the amount of cytokines, such as IL-1β, also called as “the gatekeeper of inflammation” for review see , in the host-bacterium contact site. Planktonic cells of opportunistic periodontal pathogens A. actinomycetemcomitans and F. nucleatum induce the IL-1β production from gingival epithelial cell multilayers . However, at least A. actinomycetemcomitans biofilm has the capacity to bind and internalize IL-1β , which could slow down the progression of inflammation and modify the local microenvironment more favorable for bacterial growth.
7. Conclusions and Clinical Considerations
The host-microbe interaction at the dentogingival junction may involve several detrimental mechanisms leading to periodontal pocket formation.
7.1. Bacterial Enzymes Destroy the Dento-Epithelial Junction
It is probably not a coincidence that some of the known periodontopathogens, that is, P. gingivalis and T. denticola have strong proteolytic enzymes capable of degrading all the protein components as well as the proteins of cell surface and the cell-cell junctions. Morphological studies have shown that the IBL, can be detected on the tooth surface in advanced periodontitis adjacent to degenerated DAT cells . However, this does not exclude the possibility that its molecular structures may be altered. Certain MMPs from eucaryotic cells are also able to cleave laminin-332, exposing a cryptic molecular site that triggers cell migration .
7.2. The Activated Epithelium Secretes Enzymes Degrading the Underlying Basement Membrane and Facilitates Epithelial Growth to Connective Tissue
Many bacterial products and cytokines are able to increase production of MMPs by epithelial cells. Since pathologically elevated levels of active MMPs have been found in periodontal tissues during periodontitis, the MMPs may play a role in lateral and apical migration of the JE during pocket formation [95, 165].
7.3. Adhesion of the Infected Epithelium to Tooth Is Weakened
As an example, HSP60 from A. actinomycetemcomitans has been shown to decrease the number of epithelial basement membrane binding integrin, α6β4 . This receptor is crucial for binding of JE to basement membrane. Absence of another integrin, αvβ6, that activates TGF-beta, has been suggested to play a part in the formation of periodontitis .
7.4. PMNs Secrete Enzymes Degrading the Dentogingival Junction
Many proteinases secreted by PMNs are capable of degrading basal lamina components, including laminin 332 . In already early periodontitis a great number of PMNs are migrating through gingival epithelium.
7.5. Epithelial Cells of JE Undergo Degeneration and Apoptotic or Toxic Death
Periodontopathogens producing short chain fatty acids significantly impair the rapid renewal of the coronal JE/DAT cells and thereby counteract one of the tissues main host protective functions. Bacterial metabolites, LTAs, LPSs, and other toxins are able to cause epithelial cell death at high concentrations. Degeneration and detachment of the DAT cells, loss of cellular continuity, and cell death in the coronal part of the JE and development of an intraepithelial split have been suggested in the initial phase of periodontal pathology [167–170]. Studies have also reported apoptosis in cells of pocket epithelium caused by bacterial internalization  and enhanced activation of intracellular proteases that regulate apoptosis (caspases 3 and 7) .
The crucial steps in the failure of the host defense are the loss of the epithelial barrier function, the inflammation-driven degradation of the connective tissue and osteoclast activation via the imbalance of RANKL/OPG ratio. It has become evident, that both insufficient and exaggerated inflammatory response, are detrimental to host. The inhibited or exaggerated inflammatory response results from an imbalance of pro- and anti-inflammatory cytokines.
Although periodontal pocket formation/periodontitis is a pathologic process, we should keep in mind that, the host response that causes the tissue destruction, is aimed to restrict the spreading of the infection into deeper areas. Despite of a huge number of studies on periodontitis development, we still do not have a clear picture of the crucial events leading to the periodontal tissue destruction. It is obvious, however, that many factors, including direct bacterial effects and response of the host cells are involved in this process. Once these events are better understood treatment modalities aiming at preventing periodontal pocket formation can be designed. It should be emphasized, that when treating periodontal disease, continuous control of the infection should be the first goal, and only in addition to that, modulation of the host response may be considered.
- A. D. Haffajee and S. S. Socransky, “Microbial etiological agents of destructive periodontal diseases,” Periodontology 2000, vol. 5, pp. 78–111, 1994.
- R. J. Genco, “Consensus report on periodontal diseases: pathogenesis and microbial factors,” in Annals of Periodontology, R. J. Genco, Ed., pp. 926–932, American Academy of Periodontology, Chicago, Ill, USA, 1996.
- S. S. Socransky and A. D. Haffajee, “Periodontal microbial ecology,” Periodontology 2000, vol. 38, pp. 135–187, 2005.
- P. S. Kumar, A. L. Griffen, M. L. Moeschberger, and E. J. Leys, “Identification of candidate periodontal pathogens and beneficial species by quantitative 16S clonal analysis,” Journal of Clinical Microbiology, vol. 43, no. 8, pp. 3944–3955, 2005.
- B. Zinsli Fritschi, A. Albert-Kiszely, and G. R. Persson, “Staphylococcus aureus and other bacteria in untreated periodontitis,” Journal of Dental Research, vol. 87, no. 6, pp. 589–593, 2008.
- A. P. V. Colombo, S. K. Boches, S. L. Cotton et al., “Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray,” Journal of Periodontology, vol. 80, no. 9, pp. 1421–1432, 2009.
- A. Järvensivu, J. Hietanen, R. Rautemaa, T. Sorsa, and M. Richardson, “Candida yeasts in chronic periodontitis tissues and subgingival microbial biofilms in vivo,” Oral Diseases, vol. 10, no. 2, pp. 106–112, 2004.
- X. Song, E. R. K. Eribe, J. Sun, B. F. Hansen, and I. Olsen, “Genetic relatedness of oral yeasts within and between patients with marginal periodontitis and subjects with oral health,” Journal of Periodontal Research, vol. 40, no. 6, pp. 446–452, 2005.
- A. D. Haffajee and S. S. Socransky, “Microbiology of periodontal diseases: introduction,” Periodontology 2000, vol. 38, pp. 9–12, 2005.
- J. Slots, “Herpesviruses in periodontal diseases,” Periodontology 2000, vol. 38, pp. 33–62, 2005.
- A. E. Duran-Pinedo, B. Paster, R. Teles, and J. Frias-Lopez, “Correlation network analysis applied to complex biofilm communities,” PLoS ONE, vol. 6, no. 12, Article ID e28438, 2011.
- J. Frias-Lopez and A. Duran-Pinedo, “Effect of periodontal pathogens on the metatranscriptome of a healthy multispecies biofilm model,” Journal of Bacteriology, vol. 194, no. 8, pp. 2082–2095, 2012.
- V. Cogoni, A. Morgan-Smith, J. Christopher Fenno, H. F. Jenkinson, and D. Dymock, “Treponema denticola chymotrypsin-like proteinase (CTLP) integrates spirochaetes within oral microbial communities,” Microbiology, vol. 158, no. 3, pp. 759–770, 2012.
- A. W. Aruni, F. Roy, and H. M. Fletcher, “Filifactor alocis has virulence attributes that can enhance its persistence under oxidative stress conditions and mediate invasion of epithelial cells by Porphyromonas gingivalis,” Infection and Immunity, vol. 79, no. 10, pp. 3872–3886, 2011.
- H. Shao and D. R. Demuth, “Quorum sensing regulation of biofilm growth and gene expression by oral bacteria and periodontal pathogens,” Periodontology 2000, vol. 52, no. 1, pp. 53–67, 2010.
- G. Hajishengallis, S. Liang, M. A. Payne et al., “Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement,” Cell Host and Microbe, vol. 10, no. 5, pp. 497–506, 2011.
- J. I. Salonen, “Proliferative potential of the attached cells of human junctional epithelium,” Journal of Periodontal Research, vol. 29, no. 1, pp. 41–45, 1994.
- J. Oksanen, L. M. Sorokin, I. Virtanen, and M. Hormia, “The junctional epithelium around murine teeth differs from gingival epithelium in its basement membrane composition,” Journal of Dental Research, vol. 80, no. 12, pp. 2093–2097, 2001.
- M. Bickel, “The role of interleukin-8 in inflammation and mechanisms of regulation,” Journal of Periodontology, vol. 64, no. 5, pp. 456–460, 1993.
- J. M. Crawford, “Distribution of ICAM-1, LFA-3 and HLA-DR in healthy and diseased gingival tissues,” Journal of Periodontal Research, vol. 27, no. 4, pp. 291–298, 1992.
- N. Mukaida, A. Harada, K. Yasumoto, and K. Matsushima, “Properties of pro-inflammatory cell types-specific leukocyte chemotactic cytokinetis, interleukin 8(IL-8) and monocyte chemotactic and activating factor (MCAF),” Microbiology and Immunology, vol. 36, no. 8, pp. 773–789, 1992.
- M. S. Tonetti, M. A. Imboden, L. Gerber, N. P. Lang, J. Laissue, and C. Mueller, “Localized expression of mRNA for phagocyte-specific chemotactic cytokines in human periodontal infections,” Infection and Immunity, vol. 62, no. 9, pp. 4005–4014, 1994.
- B. A. Dale, “Periodontal epithelium: a newly recognized role in health and disease,” Periodontology 2000, vol. 30, no. 1, pp. 70–78, 2002.
- M. Miyauchi, S. Sato, S. Kitagawa et al., “Cytokine expression in rat molar gingival periodontal tissues after topical application of lipopolysaccharide,” Histochemistry and Cell Biology, vol. 116, no. 1, pp. 57–62, 2001.
- K. F. Ross and M. C. Herzberg, “Calprotectin expression by gingival epithelial cells,” Infection and Immunity, vol. 69, no. 5, pp. 3248–3254, 2001.
- D. L. Diamond, J. R. Kimball, S. Krisanaprakornkit, T. Ganz, and B. A. Dale, “Detection of β-defensins secreted by human oral epithelial cells,” Journal of Immunological Methods, vol. 256, no. 1-2, pp. 65–76, 2001.
- M. Mathews, H. P. Jia, J. M. Guthmiller et al., “Production of β-defensin antimicrobial peptides by the oral mucosa and salivary glands,” Infection and Immunity, vol. 67, no. 6, pp. 2740–2745, 1999.
- Q. Lu, L. Jin, R. P. Darveau, and L. P. Samaranayake, “Expression of human β-defensins-1 and -2 peptides in unresolved chronic periodontitis,” Journal of Periodontal Research, vol. 39, no. 4, pp. 221–227, 2004.
- T. Noguchi, H. Shiba, H. Komatsuzawa et al., “Syntheses of prostaglandin E2 and E-cadherin and gene expression of β-defensin-2 by human gingival epithelial cells in response to actinobacillus actinomycetemcomitans,” Inflammation, vol. 27, no. 6, pp. 341–349, 2003.
- A. Vankeerberghen, H. Nuytten, K. Dierickx, M. Quirynen, J. J. Cassiman, and H. Cuppens, “Differential induction of human beta-defensin expression by periodontal commensals and pathogens in periodontal pocket epithelial cells,” Journal of Periodontology, vol. 76, no. 8, pp. 1293–1303, 2005.
- W. O. Chung, S. R. Hansen, D. Rao, and B. A. Dale, “Protease-activated receptor signaling increases epithelial antimicrobial peptide expression,” Journal of Immunology, vol. 173, no. 8, pp. 5165–5170, 2004.
- K. Nisapakultorn, K. F. Ross, and M. C. Herzberg, “Calprotectin expression in vitro by oral epithelial cells confers resistance to infection by Porphyromonas gingivalis,” Infection and Immunity, vol. 69, no. 7, pp. 4242–4247, 2001.
- U. K. Gursoy, E. Könönen, N. Luukkonen, and V. J. Uitto, “Human neutrophil defensins and their effect on epithelial cells,” Journal of Periodontology. In press.
- V. J. Uitto, J. I. Salonen, J. D. Firth, H. Jousimies-Somer, and U. Saarialho-Kere, “Matrilysin (matrix metalloproteinase-7) expression in human junctional epithelium,” Journal of Dental Research, vol. 81, no. 4, pp. 241–246, 2002.
- C. L. Wilson, A. J. Ouellette, D. P. Satchell et al., “Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense,” Science, vol. 286, no. 5437, pp. 113–117, 1999.
- Y. S. López-Boado, C. L. Wilson, L. V. Hooper, J. I. Gordon, S. J. Hultgren, and W. C. Parks, “Bacterial exposure induces and activates matrilysin in mucosal epithelial cells,” Journal of Cell Biology, vol. 148, no. 6, pp. 1305–1315, 2000.
- P. N. Madianos, Y. A. Bobetsis, and D. F. Kinane, “Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingiva,” Journal of Clinical Periodontology, vol. 32, no. 6, pp. 57–71, 2005.
- T. Njoroge, R. J. Genco, H. T. Sojar, N. Hamada, and C. A. Genco, “A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells,” Infection and Immunity, vol. 65, no. 5, pp. 1980–1984, 1997.
- H. Loppnow, H. Brade, E. T. Rietschel, and H. D. Flad, “Induction of cytokines in mononuclear and vascular cells by endotoxin and other bacterial products,” Methods in Enzymology, vol. 236, pp. 3–10, 1994.
- K. Monefeldt and T. Tollefsen, “Effects of a streptococcal lipoteichoic acid on complement activation in vitro,” Journal of Clinical Periodontology, vol. 20, no. 3, pp. 186–192, 1993.
- S. Bhakdi, T. Klonisch, P. Nuber, and W. Fischer, “Stimulation of monokine production by lipoteichoic acids,” Infection and Immunity, vol. 59, no. 12, pp. 4614–4620, 1991.
- E. H. Beachey and W. A. Simpson, “The adherence of group A streptococci to oropharyngeal cells: the lipoteichoic acid adhesin and fibronectin receptor,” Infection, vol. 10, no. 2, pp. 107–111, 1982.
- S. C. Holt and T. E. Bramanti, “Factors in virulence expression and their role in periodontal disease pathogenesis,” Critical Reviews in Oral Biology and Medicine, vol. 2, no. 2, pp. 177–281, 1991.
- G. Rölla, O. J. Iversen, and P. Bonesvoll, “Lipoteichoic acid—the key to the adhesiveness of sucrose grown Streptococcus mutans,” Advances in Experimental Medicine and Biology, vol. 107, pp. 607–617, 1978.
- M. T. Pöllänen, J. I. Salonen, D. Grenier, and V. J. Uitto, “Epithelial cell response to challenge of bacterial lipoteichoic acids and lipopolysaccharides in vitro,” Journal of Medical Microbiology, vol. 49, no. 3, pp. 245–252, 2000.
- I. A. Bab, M. N. Sela, I. Ginsburg, and T. Dishon, “Inflammatory lesions and bone resorption induced in the rat periodontium by lipoteichoic acid of Streptococcus mutans,” Inflammation, vol. 3, no. 4, pp. 345–358, 1979.
- E. Hausmann, B. C. Nair, and R. Dziak, “Bacterial components which result in bone loss,” in Hos Parasite Interactions in Periodontal Diseases, R. J. Genco and S. E. Merhagen, Eds., pp. 151–159, American Society for Microbiology, Washington, DC, USA, 1982.
- D. N. Tatakis and P. S. Kumar, “Etiology and pathogenesis of periodontal diseases,” Dental Clinics of North America, vol. 49, no. 3, pp. 491–516, 2005.
- A. L. Salzman, W. Hailong, P. S. Wollert et al., “Endotoxin-induced ileal mucosal hyperpermeability in pigs: role of tissue acidosis,” American Journal of Physiology, vol. 266, no. 4, pp. G633–G646, 1994.
- R. Snyderman, “Role for endotoxin and complement in periodontal tissue destruction,” Journal of Dental Research, vol. 51, no. 2, pp. 356–361, 1972.
- P. M. Bartold, A. S. Narayanan, and R. C. Page, “Platelet-derived growth factor reduces the inhibitory effects of lipopolysaccharide on gingival fibroblast proliferation,” Journal of Periodontal Research, vol. 27, no. 5, pp. 499–505, 1992.
- F. A. DeRenzis and S. Y. Chen, “Ultrastructural study of cultured human gingival fibroblasts exposed to endotoxin,” Journal of Periodontology, vol. 54, no. 2, pp. 86–90, 1983.
- S. J. Hill and J. L. Ebersole, “The effect of lipopolysaccharide on growth factor-induced mitogenesis in human gingival fibroblasts,” Journal of Periodontology, vol. 67, no. 12, pp. 1274–1280, 1996.
- S. Kamin, W. Harvey, M. Wilson, and A. Scutt, “Inhibition of fibroblast proliferation and collagen synthesis by capsular material from Actinobacillus actinomycetemcomitans,” Journal of Medical Microbiology, vol. 22, no. 3, pp. 245–249, 1986.
- H. Larjava, V. J. Uitto, E. Eerola, and M. Haapasalo, “Inhibition of gingival fibroblast growth by Bacteroides gingivalis,” Infection and Immunity, vol. 55, no. 1, pp. 201–205, 1987.
- D. L. Layman and D. L. Diedrich, “Growth inhibitory effects of endotoxins from Bacteroides gingivalis and intermedius on human gingival fibroblasts in vitro,” Journal of Periodontology, vol. 58, no. 6, pp. 387–392, 1987.
- T. Takata, M. Miyauchi, I. Ogawa, H. Ito, J. Kobayashi, and H. Nikai, “Reactive change in proliferative activity of the junctional epithelium after topical application of lipopolysaccharide,” Journal of Periodontology, vol. 68, no. 6, pp. 531–535, 1997.
- B. Zhang, B. Wang, Y. Chen, J. Yang, and J. Zhang, “Influence of lipopolysaccharide and interleukin-2 on proliferation and synthesis of sulfated macromolecules in cultured rat glomerular epithelial cells,” Chinese Medical Journal, vol. 109, no. 8, pp. 609–614, 1996.
- C. Eftimiadi, S. Valente, S. Mangiante, P. E. Mangiante, and R. Niederman, “Short chain fatty acids produced by anaerobic bacteria inhibit adhesion and proliferation of periodontal ligament fibroblasts,” Minerva Stomatologica, vol. 42, no. 11-12, pp. 481–485, 1993.
- M. T. Pöllänen, D. O. Overman, and J. I. Salonen, “Bacterial metabolites sodium butyrate and propionate inhibit epithelial cell growth in vitro,” Journal of Periodontal Research, vol. 32, no. 3, pp. 326–334, 1997.
- R. E. Singer and B. A. Buckner, “Butyrate and propionate: important components of toxic dental plaque extracts,” Infection and Immunity, vol. 32, no. 2, pp. 458–463, 1981.
- B. C. Sorkin and R. Niederman, “Short chain carboxylic acids decrease human gingival keratinocyte proliferation and increase apoptosis and necrosis,” Journal of Clinical Periodontology, vol. 25, no. 4, pp. 311–315, 1998.
- R. E. Singer and B. A. Buckner, “Propionate and butyrate induction of gingival inflammation in the beagle,” Journal of Dental Research, vol. 59, abstract, 670, 1980.
- S. Urnowey, T. Ansai, V. Bitko, K. Nakayama, T. Takehara, and S. Barik, “Temporal activation of anti- and pro-apoptotic factors in human gingival fibroblasts infected with the periodontal pathogen, Porphyromonas gingivalis: potential role of bacterial proteases in host signalling,” BMC Microbiology, vol. 6, article 26, 2006.
- S. Paju, F. Goulhen, S. Asikainen, D. Grenier, D. Mayrand, and V. J. Uitto, “Localization of heat shock proteins in clinical Actinobacillus actinomycetemcomitans strains and their effects on epithelial cell proliferation,” FEMS Microbiology Letters, vol. 182, no. 2, pp. 231–235, 2000.
- G. N. Belibasakis, M. Brage, T. Lagergård, and A. Johansson, “Cytolethal distending toxin upregulates RANKL expression in Jurkat T-cells,” Acta Pathologica, Microbiologica et Immunologica, vol. 116, no. 6, pp. 499–506, 2008.
- T. J. van Steenbergen, L. M. van der Mispel, and J. de Graaff, “Effects of ammonia and volatile fatty acids produced by oral bacteria on tissue culture cells,” Journal of Dental Research, vol. 65, no. 6, pp. 909–912, 1986.
- K. Helgeland, “Inhibitory effect of NH4Cl on secretion of collagen in human gingival fibroblasts,” Scandinavian Journal of Dental Research, vol. 92, no. 5, pp. 419–425, 1984.
- O. M. Carro, S. A. S. Evans, and C. W. Leone, “Effect of inflammation on the proliferation of human gingival epithelial cells in vitro,” Journal of Periodontology, vol. 68, no. 11, pp. 1070–1075, 1997.
- L. Vitkov, W. D. Krautgartner, and M. Hannig, “Bacterial internalization in periodontitis,” Oral Microbiology and Immunology, vol. 20, no. 5, pp. 317–321, 2005.
- E. Andrian, D. Grenier, and M. Rouabhia, “In vitro models of tissue penetration and destruction by Porphyromonas gingivalis,” Infection and Immunity, vol. 72, no. 8, pp. 4689–4698, 2004.
- D. Ekuni, T. Tomofuji, R. Yamanaka, K. Tachibana, T. Yamamoto, and T. Watanabe, “Initial apical migration of junctional epithelium in rats following application of lipopolysaccharide and proteases,” Journal of Periodontology, vol. 76, no. 1, pp. 43–48, 2005.
- L. Ren, W. K. Leung, R. P. Darveau, and L. Jin, “The expression profile of lipopolysaccharide-binding protein, membrane-bound CD14, and toll-like receptors 2 and 4 in chronic periodontitis,” Journal of Periodontology, vol. 76, no. 11, pp. 1950–1959, 2005.
- A. Uehara, K. Muramoto, H. Takada, and S. Sugawara, “Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2,” Journal of Immunology, vol. 170, pp. 5690–5696, 2003.
- L. A. Abraham, C. Chinni, A. L. Jenkins et al., “Expression of protease-activated receptor-2 by osteoblasts,” Bone, vol. 26, no. 1, pp. 7–14, 2000.
- A. Lourbakos, J. Potempa, J. Travis et al., “Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion,” Infection and Immunity, vol. 69, no. 8, pp. 5121–5130, 2001.
- R. P. Darveau, C. M. Belton, R. A. Reife, and R. J. Lamont, “Local chemokine paralysis, a novel pathogenic mechanism for porphyromonas gingivalis,” Infection and Immunity, vol. 66, no. 4, pp. 1660–1665, 1998.
- G. T. J. Huang, D. Kim, J. K. H. Lee, H. K. Kuramitsu, and S. Kinder, “Interleukin-8 and intercellular adhesion molecule 1 regulation in oral epithelial cells by selected periodontal bacteria: multiple effects of Porphyromonas gingivalis via antagonistic mechanisms,” Infection and Immunity, vol. 69, no. 3, pp. 1364–1372, 2001.
- M. Holzhausen, L. C. Spolidorio, and N. Vergnolle, “Proteinase-activated receptor-2 (PAR2) agonist causes periodontitis in rats,” Journal of Dental Research, vol. 84, no. 2, pp. 154–159, 2005.
- J. J. Reynolds, “Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation,” Oral Diseases, vol. 2, no. 1, pp. 70–76, 1996.
- L. Hakkinen, J. Heino, L. Kiovisto, and H. Larjava, “Altered interaction of human granulation-tissue fibroblasts with fibronectin is regulated α5β1 integrin,” Biochimica et Biophysica Acta, vol. 1224, no. 1, pp. 33–42, 1994.
- L. Häkkinen and H. Larjava, “Characterization of fibroblast clones from periodontal granulation tissue in vitro,” Journal of Dental Research, vol. 71, no. 12, pp. 1901–1907, 1992.
- R. C. Page and H. E. Schroeder, “Pathogenesis of inflammatory periodontal disease: a summary of current work,” Laboratory Investigation, vol. 34, no. 3, pp. 235–249, 1976.
- D. F. Kinane and J. Lindhe, “Pathogenesis of periodontitis,” in Clinical Periodontology and Implant dentistry, J. Lindhe, T. Karring, and N. P. lang, Eds., pp. 189–225, Munksgaard, Copenhagen, Denmark, 1997.
- A. Beklen, M. Ainola, M. Hukkanen, C. Gürgan, T. Sorsa, and Y. T. Konttinen, “MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis,” Journal of Dental Research, vol. 86, no. 4, pp. 347–351, 2007.
- H. Domeij, T. Modéer, and T. Yucel-Lindberg, “Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 production in human gingival fibroblasts: the role of protein kinase C,” Journal of Periodontal Research, vol. 39, no. 5, pp. 308–314, 2004.
- J. J. Reynolds and M. C. Meikle, “Mechanisms of connective tissue matrix destruction in periodontitis,” Periodontology 2000, vol. 1997, no. 14, pp. 144–157, 1997.
- Z. Feng and A. Weinberg, “Role of bacteria in health and disease of periodontal tissues,” Periodontology 2000, vol. 40, no. 1, pp. 50–76, 2006.
- J. Carlsson, B. F. Herrmann, J. F. Hofling, and G. K. Sundqvist, “Degradation of the human proteinase inhibitors alpha-1-antitrypsin and alpha-2-macroglobulin by Bacteroides gingivalis,” Infection and Immunity, vol. 43, no. 2, pp. 644–648, 1984.
- L. Sandholm, “Proteases and their inhibitors in chronic inflammatory periodontal disease,” Journal of Clinical Periodontology, vol. 13, no. 1, pp. 19–26, 1986.
- T. Nilsson, J. Carlsson, and G. Sundqvist, “Inactivation of key factors of the plasma proteinase cascade systems by Bacteroides gingivalis,” Infection and Immunity, vol. 50, no. 2, pp. 467–471, 1985.
- D. Nelson, J. Potempa, T. Kordula, and J. Travis, “Purification and characterization of a novel cysteine proteinase (periodontain) from Porphyromonas gingivalis: evidence for a role in the inactivation of human α1-proteinase inhibitor,” Journal of Biological Chemistry, vol. 274, no. 18, pp. 12245–12251, 1999.
- H. Birkedal-Hansen, “Role of cytokines and inflammatory mediators in tissue destruction,” Journal of Periodontal Research, vol. 28, no. 6, pp. 500–510, 1993.
- T. Kubota, T. Nomura, T. Takahashi, and K. Hara, “Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue,” Archives of Oral Biology, vol. 41, no. 3, pp. 253–262, 1996.
- Y. T. Teng, J. Sodek, and C. A. McCulloch, “Gingival crevicular fluid gelatinase and its relationship to periodontal disease in human subjects,” Journal of Periodontal Research, vol. 27, no. 5, pp. 544–552, 1992.
- M. Soell, R. Elkaim, and H. Tenenbaum, “Cathepsin C, matrix metalloproteinases, and their tissue inhibitors in gingiva and gingival crevicular fluid from periodontitis-affected patients,” Journal of Dental Research, vol. 81, no. 3, pp. 174–178, 2002.
- T. Sorsa, L. Tjäderhane, and T. Salo, “Matrix metalloproteinases (MMPs) in oral diseases,” Oral Diseases, vol. 10, no. 6, pp. 311–318, 2004.
- M. Hernandez, M. A. Valenzuela, C. Lopez-Otin et al., “Matrix metalloproteinase-13 is highly expressed in destructive periodontal disease activity,” Journal of Periodontology, vol. 77, no. 11, pp. 1863–1870, 2006.
- M. Mäkelä, T. Salo, V. J. Uitto, and H. Larjava, “Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status,” Journal of Dental Research, vol. 73, no. 8, pp. 1397–1406, 1994.
- V. J. Uitto, C. M. Overall, and C. McCulloch, “Proteolytic host cell enzymes in gingival crevice fluid,” Periodontology 2000, vol. 31, pp. 77–104, 2003.
- P. Pozo, M. A. Valenzuela, C. Melej et al., “Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients,” Journal of Periodontal Research, vol. 40, no. 3, pp. 199–207, 2005.
- M. Lorencini, J. A. F. Silva, C. A. Almeida, A. Bruni-Cardoso, H. F. Carvalho, and D. R. Stach-Machado, “A new paradigm in the periodontal disease progression: gingival connective tissue remodeling with simultaneous collagen degradation and fibers thickening,” Tissue and Cell, vol. 41, no. 1, pp. 43–50, 2009.
- R. Attström, “Studies on neutrophil polymorphonuclear leukocytes at the dento-gingival junction in gingival health and disease,” Journal of Periodontal Research, vol. 8, supplement, pp. 1–15, 1971.
- P. R. Garant, “Plaque: neutrophil interaction in monoinfected rats as visualized by transmission electron microscopy,” Journal of Periodontology, vol. 47, no. 3, pp. 132–138, 1976.
- J. B. Matthews, H. J. Wright, A. Roberts, N. Ling-Mountford, P. R. Cooper, and I. L. C. Chapple, “Neutrophil hyper-responsiveness in periodontitis,” Journal of Dental Research, vol. 86, no. 8, pp. 718–722, 2007.
- T. Sorsa, K. Suomalainen, and V. J. Uitto, “The role of gingival crevicular fluid and salivary interstitial collagenases in human periodontal diseases,” Archives of Oral Biology, vol. 35, no. 1, pp. S193–S196, 1990.
- P. Visca, F. Berlutti, P. Vittorioso, C. Dalmastri, M. C. Thaller, and P. Valenti, “Growth and adsorption of Streptococcus mutans 6715-13 to hydroxyapatite in the presence of lactoferrin,” Medical Microbiology and Immunology, vol. 178, no. 2, pp. 69–79, 1989.
- R. M. Wilson and W. G. Reeves, “Neutrophil phagocytosis and killing in insulin-dependent diabetes,” Clinical and Experimental Immunology, vol. 63, no. 2, pp. 478–484, 1986.
- L. C. Altman, C. Baker, P. Fleckman, D. Luchtel, and D. Oda, “Neutrophil-mediated damage to human gingival epithelial cells,” Journal of Periodontal Research, vol. 27, no. 1, pp. 70–79, 1992.
- D. K. Dennison and T. E. Van Dyke, “The acute inflammatory response and the role of phagocytic cells in periodontal health and disease,” Periodontology 2000, vol. 1997, no. 14, pp. 54–78, 1997.
- J. Carlsson, “Growth and nutrition as ecological factors,” in Oral Bacterial Ecology: The Molecular Basis, H. Kuramitsu and R. Ellen, Eds., pp. 67–130, Horizon Scientific Press, Norfolk, Va, USA, 2000.
- M. T. Pöllänen, J. I. Salonen, and V. J. Uitto, “Structure and function of the tooth-epithelial interface in health and disease,” Periodontology 2000, vol. 31, pp. 12–31, 2003.
- L. M. Golub, H. M. Lee, R. A. Greenwald et al., “A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis,” Inflammation Research, vol. 46, no. 8, pp. 310–319, 1997.
- P. Permpanich, M. J. Kowolik, and D. M. Galli, “Resistance of fluorescent-labelled Actinobacillus actinomycetemcomitans strains to phagocytosis and killing by human neutrophils,” Cellular Microbiology, vol. 8, no. 1, pp. 72–84, 2006.
- R. K. Liu, C. F. Cao, H. X. Meng, and Y. Gao, “Polymorphonuclear neutrophils and their mediators in gingival tissues from generalized aggressive periodontitis,” Journal of Periodontology, vol. 72, no. 11, pp. 1545–1553, 2001.
- A. Güntsch, M. Erler, P. M. Preshaw, B. W. Sigusch, G. Klinger, and E. Glockmann, “Effect of smoking on crevicular polymorphonuclear neutrophil function in periodontally healthy subjects,” Journal of Periodontal Research, vol. 41, no. 3, pp. 184–188, 2006.
- A. Gustafsson, H. Ito, B. Åsman, and K. Bergström, “Hyper-reactive mononuclear cells and neutrophils in chronic periodontitis,” Journal of Clinical Periodontology, vol. 33, no. 2, pp. 126–129, 2006.
- E. A. Nicu, U. Van Der Velden, V. Everts, A. J. Van Winkelhoff, D. Roos, and B. G. Loos, “Hyper-reactive PMNs in FcγRIIa 131 H/H genotype periodontitis patients,” Journal of Clinical Periodontology, vol. 34, no. 11, pp. 938–945, 2007.
- F. Ghannad, D. Nica, M. I. Garcia Fulle et al., “Absence of αvβ6 integrin is linked to initiation and progression of periodontal disease,” American Journal of Pathology, vol. 172, no. 5, pp. 1271–1286, 2008.
- G. Hajishengallis and J. D. Lambris, “Microbial manipulation of receptor crosstalk in innate immunity,” Nature Reviews Immunology, vol. 11, no. 3, pp. 187–200, 2011.
- H. Rus, C. Cudrici, and F. Niculescu, “The role of the complement system in innate immunity,” Immunologic Research, vol. 33, no. 2, pp. 103–112, 2005.
- R. Attstrom, A. B. Laurel, U. Lahsson, and A. Sjoholm, “Complement factors in gingival crevice material from healthy and inflamed gingiva in humans,” Journal of Periodontal Research, vol. 10, no. 1, pp. 19–27, 1975.
- H. A. Schenkein and R. J. Genco, “Gingival fluid and serum in periodontal diseases. I. Quantitative study of immunoglobulins, complement components, and other plasma proteins,” Journal of Periodontology, vol. 48, no. 2, pp. 772–777, 1977.
- H. A. Schenkein and R. J. Genco, “Gingival fluid and serum in periodontal diseases. II. Evidence for cleavage of complement components C3, C3 proactivator (factor B) and C4 in gingival fluid,” Journal of Periodontology, vol. 48, no. 2, pp. 778–784, 1977.
- K. Monefeldt, K. Helgeland, and T. Tollefsen, “In vitro cleavage of serum complement protein C3: a comparison between patients with adult periodontitis and periodontally healthy persons,” Journal of Clinical Periodontology, vol. 22, no. 1, pp. 45–51, 1995.
- J. A. Wingrove, R. G. DiScipio, Z. Chen, J. Potempa, J. Travis, and T. E. Hugli, “Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis,” Journal of Biological Chemistry, vol. 267, no. 26, pp. 18902–18907, 1992.
- T. Yamazaki, M. Miyamoto, S. Yamada, K. Okuda, and K. Ishihara, “Surface protease of Treponema denticola hydrolyzes C3 and influences function of polymorphonuclear leukocytes,” Microbes and Infection, vol. 8, no. 7, pp. 1758–1763, 2006.
- E. P. Næsse, O. Schreurs, K. Helgeland, K. Schenck, and S. Steinsvoll, “Matrix metalloproteinases and their inhibitors in gingival mast cells in persons with and without human immunodeficiency virus infection,” Journal of Periodontal Research, vol. 38, no. 6, pp. 575–582, 2003.
- M. R. Patters, C. E. Niekrash, and N. P. Lang, “Assessment of complement cleavage in gingival fluid during experimental gingivitis in man,” Journal of Clinical Periodontology, vol. 16, no. 1, pp. 33–37, 1989.
- R. Rautemaa and S. Meri, “Protection of gingival epithelium against complement-mediated damage by strong expression of the membrane attack complex inhibitor protectin (CD59),” Journal of Dental Research, vol. 75, no. 1, pp. 568–574, 1996.
- M. S. Tonetti, “Molecular factors associated with compartmentalization of gingival immune responses and transepithelial neutrophil migration,” Journal of Periodontal Research, vol. 32, no. 1, pp. 104–109, 1997.
- M. A. Jagels, J. A. Ember, J. Travis, J. Potempa, R. Pike, and T. E. Hugli, “Cleavage of the human C5a receptor by proteinases derived from porphyromonas gingivalis: cleavage of leukocyte C5a Receptor,” Advances in Experimental Medicine and Biology, vol. 389, pp. 155–164, 1996.
- N. Yamaguchi, H. Tsuda, Y. Yamashita, and T. Koga, “Binding of the capsule-like serotype-specific polysaccharide antigen and the lipopolysaccharide from Actinobacillus actinomycetemcomitans to human complement-derived opsonins,” Oral Microbiology and Immunology, vol. 13, no. 6, pp. 348–354, 1998.
- T. Imamura, J. Travis, and J. Potempa, “The biphasic virulence activities of gingipains: activation and inactivation of host proteins,” Current Protein and Peptide Science, vol. 4, no. 6, pp. 443–450, 2003.
- K. Popadiak, J. Potempa, K. Riesbeck, and A. M. Blom, “Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system,” Journal of Immunology, vol. 178, no. 11, pp. 7242–7250, 2007.
- M. Seppänen, M. L. Lokki, I. L. Notkola et al., “Complement and C4 null alleles in severe chronic adult periodontitis,” Scandinavian Journal of Immunology, vol. 65, no. 2, pp. 176–181, 2007.
- C. W. Cutler and Y. T. A. Teng, “Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists,” Periodontology 2000, vol. 45, no. 1, pp. 35–50, 2007.
- K. S. Kornman, “The interleukin-1 genotype as a severity factor in adult periodontal disease,” Journal of Clinical Periodontology, vol. 24, no. 1, pp. 72–77, 1997.
- K. S. Kornman and F. S. di Giovine, “Genetic variations in cytokine expression: a risk factor for severity of adult periodontitis,” Annals of Periodontology, vol. 3, no. 1, pp. 327–338, 1998.
- T. C. Hart and K. S. Kornman, “Genetic factors in the pathogenesis of periodontitis,” Periodontology 2000, vol. 1997, no. 14, pp. 202–215, 1997.
- G. Greenstein and T. C. Hart, “Clinical utility of a genetic susceptibility test for severe chronic periodontitis: a critical evaluation,” Journal of the American Dental Association, vol. 133, no. 4, pp. 452–459, 2002.
- G. Greenstein and T. C. Hart, “A critical assessment of interleukin-1 (IL-1) genotyping when used in a genetic susceptibility test for severe chronic periodontitis,” Journal of Periodontology, vol. 73, no. 2, pp. 231–247, 2002.
- Y. T. A. Teng, “Protective and destructive immunity in the periodontium—part 1—innate and humoral immunity and the periodontium,” Journal of Dental Research, vol. 85, no. 3, pp. 198–208, 2006.
- P. Kidd, “Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease,” Alternative Medicine Review, vol. 8, no. 3, pp. 223–246, 2003.
- D. F. Kinane and D. F. Lappin, “Immune processes in periodontal disease: a review,” Annals of Periodontology, vol. 7, no. 1, pp. 62–71, 2002.
- M. H. Napimoga, L. H. A. C. Nunes, A. A. B. Maciel et al., “Possible Involvement of IL-21 and IL-10 on Salivary IgA Levels in Chronic Periodontitis Subjects,” Scandinavian Journal of Immunology, vol. 74, no. 6, pp. 596–602, 2011.
- P. J. Pussinen, E. Könönen, S. Paju et al., “Periodontal pathogen carriage, rather than periodontitis, determines the serum antibody levels,” Journal of Clinical Periodontology, vol. 38, no. 5, pp. 405–411, 2011.
- E. Gemmell, K. Yamazaki, and G. J. Seymour, “Destructive periodontitis lesions are determined by the nature of the lymphocytic response,” Critical Reviews in Oral Biology and Medicine, vol. 13, no. 1, pp. 17–34, 2002.
- K. Yamazaki, H. Yoshie, and G. J. Seymour, “T cell regulation of the immune response to infection in periodontal diseases,” Histology and Histopathology, vol. 18, no. 3, pp. 889–896, 2003.
- M. A. Taubman, P. Valverde, X. Han, and T. Kawai, “Immune response: they key to bone resorption in periodontal disease,” Journal of Periodontology, vol. 76, no. 11, pp. 2033–2041, 2005.
- Y. T. A. Teng, “Protective and destructive immunity in the periodontium—part 2—T-cell-mediated immunity in the periodontium,” Journal of Dental Research, vol. 85, no. 3, pp. 209–219, 2006.
- Y. Choi, K. M. Woo, S.-H. Ko, Y. J. Lee, S.-J. Park, and H.-M. Kim, “Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8+ T cells,” European Journal of Immunology, vol. 31, no. 7, pp. 2179–2188, 2001.
- Y. Y. Kung, U. Felge, I. Sarosi et al., “Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand,” Nature, vol. 402, no. 6759, pp. 304–309, 1999.
- G. J. Seymour and E. Gemmell, “Cytokines in periodontal disease: where to from here?” Acta Odontologica Scandinavica, vol. 59, no. 3, pp. 167–173, 2001.
- D. L. Cochran, “Inflammation and bone loss in periodontal disease,” Journal of Periodontology, vol. 79, no. 8, pp. 1569–1576, 2008.
- N. Wara-Aswapati, R. Surarit, A. Chayasadom, J. A. Boch, and W. Pitiphat, “RANKL upregulation associated with periodontitis and porphyromonas gingivalis,” Journal of Periodontology, vol. 78, no. 6, pp. 1062–1069, 2007.
- J. I. Salonen, M. B. Kautsky, and B. A. Dale, “Changes in cell phenotype during regeneration of junctional epithelium of human gingiva in vitro,” Journal of Periodontal Research, vol. 24, no. 6, pp. 370–377, 1989.
- J. Oksanen and M. Hormia, “An organotypic in vitro model that mimics the dento-epithelial junction,” Journal of Periodontology, vol. 73, no. 1, pp. 86–93, 2002.
- U. K. Gursoy, M. Pöllänen, E. Könönen, and V.-J. Uitto, “A novel organotypic dento-epithelial culture model: effect of fusobacterium nucleatum biofilm on B-defensin-2, -3, and LL-37 expression,” Journal of Periodontology, vol. 83, no. 2, pp. 242–247, 2012.
- B. C. Dickinson, C. E. Moffatt, D. Hagerty et al., “Interaction of oral bacteria with gingival epithelial cell multilayers,” Molecular Oral Microbiology, vol. 26, no. 3, pp. 210–220, 2011.
- C. A. Dinarello, “A clinical perspective of IL-1β as the gatekeeper of inflammation,” European Journal of Immunology, vol. 41, no. 5, pp. 1203–1217, 2011.
- A. Paino, H. Tuominen, M. Jääskeläinen et al., “Trimeric form of intracellular ATP synthase subunit β of aggregatibacter actinomycetemcomitans binds human interleukin-1β,” PLoS ONE, vol. 6, no. 4, Article ID e18929, 2011.
- D. O. Overman and J. I. Salonen, “Characterization of the human junctional epithelial cells directly attached to the tooth (DAT cells) in periodontal disease,” Journal of Dental Research, vol. 73, no. 12, pp. 1818–1823, 1994.
- G. Giannelli, J. Falk-Marzillier, O. Schiraldi, W. G. Stetler-Stevenson, and V. Quaranta, “Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5,” Science, vol. 277, no. 5323, pp. 225–228, 1997.
- V. J. Uitto, K. Airola, M. Vaalamo et al., “Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation,” American Journal of Pathology, vol. 152, no. 6, pp. 1489–1499, 1998.
- L. Zhang, L. Koivisto, J. Heino, and V. J. Uitto, “Bacterial heat shock protein 60 may increase epithelial cell migration through activation of MAP kinases and inhibition of α6β4 integrin expression,” Biochemical and Biophysical Research Communications, vol. 319, no. 4, pp. 1088–1095, 2004.
- S. Schluger, “Periodontics today: dentistry tomorrow,” District of Columbia Dental Society Journal, pp. 6–8, 1977.
- H. E. Schroeder and M. A. Listgarten, “The gingival tissues: the architecture of periodontal protection,” Periodontology 2000, vol. 14, no. 1, pp. 91–120, 1997.
- T. Takata and K. Donath, “The mechanism of pocket formation. A light microscopic study on undecalcified human material,” Journal of Periodontology, vol. 59, no. 4, pp. 215–221, 1988.
- D. D. Bosshardt and N. P. Lang, “The junctional epithelium: from health to disease,” Journal of Dental Research, vol. 84, no. 1, pp. 9–20, 2005.
- L. Vitkov, W. D. Krautgartner, and M. Hannig, “Surface morphology of pocket epithelium,” Ultrastructural Pathology, vol. 29, no. 2, pp. 121–127, 2005.
- H. Bantel, T. Beikler, T. F. Flemmig, and K. Schulze-Osthoff, “Caspase activation is involved in chronic periodontitis,” FEBS Letters, vol. 579, no. 25, pp. 559–5564, 2005.